UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's Disease

Journal of neurochemistry, 2000-11, Vol.75 (5), p.2190-2199

2000

Volltextzugriff (PDF)

The dopaminergic stabilizer, (−)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins

Brain research, 2012-06, Vol.1459, p.100-112

2012

Volltextzugriff (PDF)

Bone morphogenetic protein-6 is a neurotrophic factor for calbindin-positive striatal neurons

Journal of neuroscience research, 2002-12, Vol.70 (5), p.638-644

2002

Volltextzugriff (PDF)

Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N -methyl- d -aspartate receptors

Neuroscience, 2007-01, Vol.144 (2), p.462-471

2007

Volltextzugriff (PDF)

Brain‐derived neurotrophic factor (BDNF) mediates bone morphogenetic protein‐2 (BMP‐2) effects on cultured striatal neurones

Journal of neurochemistry, 2001-11, Vol.79 (4), p.747-755

2001

Volltextzugriff (PDF)

Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo

Neuroscience, 1999-01, Vol.91 (4), p.1257-1264

1999

Volltextzugriff (PDF)

Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage

Neuroscience, 1996-11, Vol.75 (2), p.345-352

1996

Volltextzugriff (PDF)

Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain

The European journal of neuroscience, 2006-02, Vol.23 (3), p.649-658

2006

Volltextzugriff (PDF)

Differential Effects of Glial Cell Line‐Derived Neurotrophic Factor and Neurturin on Developing and Adult Substantia Nigra Dopaminergic Neurons

Journal of neurochemistry, 1999-07, Vol.73 (1), p.70-78

1999

Volltextzugriff (PDF)

Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease

Experimental neurology, 2004-11, Vol.190 (1), p.42-58

2004

Volltextzugriff (PDF)

Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members

Journal of neurochemistry, 2001-09, Vol.78 (6), p.1287-1296

2001

Volltextzugriff (PDF)

Differential involvement of phosphatidylinositol 3-kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons

Molecular and cellular neuroscience, 2004-03, Vol.25 (3), p.460-468

2004

Volltextzugriff (PDF)

The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development

International journal of developmental neuroscience, 2005-06, Vol.23 (4), p.343-349

2005

Volltextzugriff (PDF)

BDNF Up-Regulates TrkB Protein and Prevents the Death of CA1 Neurons Following Transient Forebrain Ischemia

Brain pathology (Zurich, Switzerland), 1998-04, Vol.8 (2), p.253-261

1998

Volltextzugriff (PDF)

Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury

Brain research. Molecular brain research., 2005-03, Vol.134 (1), p.147-154

2005

Volltextzugriff (PDF)

Nerve Growth Factor and Basic Fibroblast Growth Factor Protect Cholinergic Neurons Against Quinolinic Acid Excitotoxicity in Rat Neostriatum

The European journal of neuroscience, 1994-05, Vol.6 (5), p.706-711

1994

Volltextzugriff (PDF)

Postnatal development of functional dopamine, opioid and tachykinin receptors that regulate acetylcholine release from rat neostriatal slices. Effect of 6‐hydroxydopamine lesion

International journal of developmental neuroscience, 1993-12, Vol.11 (6), p.701-708

1993

Volltextzugriff (PDF)

Selective resistance of tachykinin-responsive cholinergic neurons in the quinolinic acid lesioned neostriatum

Brain research, 1993-02, Vol.603 (2), p.317-320

1993

Volltextzugriff (PDF)

Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons

Naunyn-Schmiedeberg's archives of pharmacology, 1993-11, Vol.348 (5), p.445-449

1993

Volltextzugriff (PDF)

Bone morphogenetic protein‐2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons

Journal of neurobiology, 1999-02, Vol.38 (2), p.161-170

1999

Volltextzugriff (PDF)

BMP‐2 and cAMP elevation confer locus coeruleus neurons responsiveness to multiple neurotrophic factors

Journal of neurobiology, 2002-03, Vol.50 (4), p.291-304

2002

Volltextzugriff (PDF)

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity

Neurobiology of disease, 2009-12, Vol.36 (3), p.461-469

2009

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

ThemaNeurons - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Brain‐Derived Neurotrophic Factor, Neurotrophin‐3, and Neurotrophin‐4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntington's Disease

The dopaminergic stabilizer, (−)-OSU6162, rescues striatal neurons with normal and expanded polyglutamine chains in huntingtin protein from exposure to free radicals and mitochondrial toxins

Bone morphogenetic protein-6 is a neurotrophic factor for calbindin-positive striatal neurons

Mice heterozygous for neurotrophin-3 display enhanced vulnerability to excitotoxicity in the striatum through increased expression of N -methyl- d -aspartate receptors

Brain‐derived neurotrophic factor (BDNF) mediates bone morphogenetic protein‐2 (BMP‐2) effects on cultured striatal neurones

Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo

Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage

Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain

Differential Effects of Glial Cell Line‐Derived Neurotrophic Factor and Neurturin on Developing and Adult Substantia Nigra Dopaminergic Neurons

Induction of GABAergic phenotype in a neural stem cell line for transplantation in an excitotoxic model of Huntington's disease

Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members

Differential involvement of phosphatidylinositol 3-kinase and p42/p44 mitogen activated protein kinase pathways in brain-derived neurotrophic factor-induced trophic effects on cultured striatal neurons

The vulnerability of striatal projection neurons and interneurons to excitotoxicity is differentially regulated by dopamine during development

BDNF Up-Regulates TrkB Protein and Prevents the Death of CA1 Neurons Following Transient Forebrain Ischemia

Endogenous brain-derived neurotrophic factor protects dopaminergic nigral neurons against transneuronal degeneration induced by striatal excitotoxic injury

Nerve Growth Factor and Basic Fibroblast Growth Factor Protect Cholinergic Neurons Against Quinolinic Acid Excitotoxicity in Rat Neostriatum

Postnatal development of functional dopamine, opioid and tachykinin receptors that regulate acetylcholine release from rat neostriatal slices. Effect of 6‐hydroxydopamine lesion

Selective resistance of tachykinin-responsive cholinergic neurons in the quinolinic acid lesioned neostriatum

Control of tachykinin-evoked acetylcholine release from rat striatal slices by dopaminergic neurons

Bone morphogenetic protein‐2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons

BMP‐2 and cAMP elevation confer locus coeruleus neurons responsiveness to multiple neurotrophic factors

Reduced calcineurin protein levels and activity in exon-1 mouse models of Huntington's disease: Role in excitotoxicity

Aktive Filter

Suchergebnisse filtern